Tuesday, March 1, 2011

Medical Products Development & Policy (PHARM 532 SLN 16921)

MW 1:00-2:50
SOCC 309
Faculty: Tom Hazlet, PharmD, Dr. P.H.
Lou Garrison, PhD

Topics to include, among others:
Regulatory and Quasi-regulatory structures
Non-clinical Evaluation of Medical Products
Clinical Trials
IRBs, HIPAA & BiMO
Post-marketing Obligations

This class in Medical Products Development and Policy would be of interest to those in the following disciplines:
health policy, bioengineering, health services, pharmacy policy, law, political science as it relates to health care, business majors interested in healthcare fields.